You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a Topical Choroid Plexus Factor Product to Accelerate Wound Healin

    SBC: CYTOSOLV INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Chronic superficial wounds are difficult to treat and often never completely heal. Diabetic foot complications account for the majority of lower limb amputations in the world, and 25% of all diabetic hospital admissionsin the US. The standard of care for these wounds has been unchanged for decades, and remains reduced weight bearing, debridement, antibiotics, a ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries

    SBC: SARMONT, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Nitric oxide (NO) has been shown to have powerful, broad-spectrum antimicrobial activity as well as benefits in wound healing when properly administered [1-3]. The combination of these two attributes makes development of a non-systemic NO delivery approach valuable for hospital and outpatient applications to prevent infection and accelerate wound healing. Such ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. A Probabilistic Pose Estimation Algorithm for 3D Motion Capture Data

    SBC: C-MOTION, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): A major challenge facing rehabilitation research is to measure relationships between impairments, functional limitations, and disabilities. Biomechanical analyses are a key tool for establishing these relationships byproviding quantitative objective measures of patient status and treatment outcomes. At the heart of many biomechanical analyses is estimation of ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. IPF Drug Discovery Proof of Principle

    SBC: VERACITY BIOTECHNOLOGY, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Activated fibroblasts are the key mediators of fibrosis and these cells are derived from both resident cells as well as from circulating cells termed fibrocytes. Fibrocytes are known to contribute significantly to the total population of fibroblasts in a variety of progressive fibrotic diseases including idiopathic pulmonary fibrosis (IPF), a progressive and fa ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Empowering SCD Patients with Web Tools to Improve Care Communications

    SBC: MEDICAL DECISION LOGIC INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): The pioneering and strategic goal of this SBIR project Empowering SCD Patients with Web Tools to Improve Care Communications is to create a specialized niche product that improves emergency department (ED) treatment of patients with sickle cell disease (SCD) presenting with a painful crisis, decreasing costly hospital admissions. At present, the unfortunate n ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Development of tools to modify globin gene expression in stem cells

    SBC: RETROTHERAPY, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Development of tools to modify globin gene expression in stem cells The objective of this proposal is to develop a treatment for patients with sickle cell disease. The development of methods for treating common geneticdiseases, such as sickle cell disease remains an elusive goal. Gene therapy is a technology which has the potential to overcome several of the pr ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Enhanced system for atrial defibrillation

    SBC: CARDIALEN, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most prevalent clinical arrhythmia in clinical practice and a major contributor to morbidity and mortality. A recent study estimated that the number of Americans afflicted by AF will increase from the current range of 2.2 to 5.6 million to more than 12 million by 2050. This increase will be driven significantly by demographics, s ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Preclinical Development of a Novel and Effective Treatment for Cough

    SBC: Cerecor Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): The mainstays of symptomatic antitussive therapy, dextromethorphan (DXM) and codeine, are no better than placebo in the majority of controlled clinical trials and have high abuse liability. A lack of knowledge regardingthe mechanisms of cough has hindered the discovery of new treatments over the past few decades. Recent discoveries of peripheral cough receptors ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a mobile robot with an affective interface and human activity trac

    SBC: Intelligent Automation, Inc.            Topic: NLM

    Project Summary Socially assistive robots (SARs) have the potential to significantly improve overall health and quality of life for aging individuals. We propose to develop a novel SAR that provides personalized physical and cognitive assistance and motivation to elderly users to improve their overall health and well-being. The Specific Aims for Phase I are 1) to develop an affective interface fo ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Development of a clinical robotic device for diagnosis, rehabilitation and treatm

    SBC: TECHNO-SCIENCES, LLC            Topic: NLM

    DESCRIPTION (provided by applicant): Anterior Cruciate Ligament (ACL) injury afflicts at least 200,000 young Americans annually. At least, 50 percent of individuals develop Osteoarthritis (OA) in the ten years after the injury and this imposes a substantial burden on the U.S. health care system. The gold standard for treating the ACL-injured individual is unknown, despite the vast array of su ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government